Optometrist Canyon City Eyecare Azusa, California, United States
Disclosure(s): No relevant disclosure to display
Disclosure(s):
Milton M. Hom, OD: No relevant disclosure to display
Is Optometry entering into the golden age of new therapeutics? Not just new drugs, but new drug classes for those frustrating chronic conditions. Two of these new classes are refractive: presbyopia and myopia. Although the classes are new, the drugs are old but not yet worn out. Ocular surface medications for chronic conditions are the next two classes: Demodex blepharitis and meibomian gland dysfunction (MGD). Help is on the way for increasing myopia, Demodex infestation, MGD, and presbyopia.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Learn about parasitic blepharitis
Learn about meibomian gland dysfunction (MGD) and causes
Know the pitfalls of refractive drugs
Understand the optics behind refractive drugs
Learn about past treatment strategies for chronic ocular surface disease
